Top 20 biopharma market caps fall 5.7% amid industry challenges
Bristol Myers Squibb saw the largest decline at -22.9%, with Regeneron at -18.7% and Sanofi at -13.8%.
Bristol Myers Squibb saw the largest decline at -22.9%, with Regeneron at -18.7% and Sanofi at -13.8%.